IP Verse

Puren competitive analysis

Loading summary...

Latest oppositions filed by Puren

Explore patent oppositions filed by Puren against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3578175
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 29, 2023
EP3578173
Dosage Form Containing Oxycodone And NaloxoneEURO CELTIQUEJul 26, 2023
EP3260117
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENMay 25, 2021
EP3342411
Rapamycin Derivative For Treating Pancreas CancerNOVARTISApr 29, 2020

Latest patents of Puren opposed by its competitors

Explore Puren's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3371250
May 6, 2020Functional Material Having At Least One Additive2

Latest publications and patents of Puren New

Explore the latest publications and patents granted to Puren, showcasing their recent innovations and technological advancements.

Last updated on: Oct 16, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Puren

EP3371250
May 6, 2020Functional Material Having At Least One AdditiveGranted And Under Opposition

Latest PTAB cases involving Puren

Discover the latest PTAB cases involving Puren, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Puren with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PUREN PHARMA3 - - -
AMGEN8138811
EURO CELTIQUE - 44 - -
NOVARTIS6422 - 21